AABB Publishes Software Interface Guidelines for Donor Hemovigilance System

Letter from FDA Outlines “Path Forward” to Resume Oxycyte Clinical Trials

Agenda, Briefing Papers Released for April BPAC Meeting

FDA, NIH to Host Workshop on GVHD After Stem Cell Transplantation

Dana Foundation Offering Research Grants in Immunology